Effectiveness of the CardioPain initiative in reducing inappropriate NSAID prescriptions in pain therapy among high cardiovascular risk patients: an informative Italian survey.
OBJECTIVE
Non-steroidal anti-inflammatory drugs (NSAIDs) and COX-2 inhibitors (COXIBs) may be associated with increased cardiovascular (CV) risk and mortality in CV patients. After the release of Note 66 by Agenzia Italiana del Farmaco (AIFA) to reduce inappropriate prescribing of NSAIDs and COXIBs, the CARDIOPAIN initiative was started in Italy to include such recommendations into the hospital discharge letter of patients with high CV risk. We evaluated the effect of the CARDIOPAIN initiative on the prescription of analgesic drugs by general practitioners (GPs).


METHODS
An online interview was proposed to 414 Italian GPs. A descriptive statistic was reported.


RESULTS
Three groups of GPs were identified: those who found the Note 66 recommendations in most hospital discharge letters (the "MOST" group), those who found them in only few cases (the "FEW" group) and those who never found the recommendations (the "NO" group). In patients with high CV risk, the percentage of GPs prescribing NSAIDs as first choice in pain management was lower in the MOST group compared with the "FEW" or "NO" groups. GPs belonging to the "MOST" group prescribed NSAIDs in 28% of cases, compared with 50% of cases observed for GPs belonging to the "NO" group. The more severe the pathology the fewer the NSAID prescriptions, in favor of opioid agents administration.


CONCLUSIONS
Our results suggest that the inclusion of the AIFA Note 66 in the discharge documents of high CV risk patients may have contributed to lower inappropriate NSAID prescriptions in Italian GPs. Presumably, a wider diffusion of the CARDIOPAIN initiative might improve the prescription appropriateness of analgesic drugs.
CIRFF, Center of Pharmacoeconomics, Federico II University of Naples, Naples - Italy.
Valentina
V
Orlando
CIRFF, Center of Pharmacoeconomics, Federico II University of Naples, Naples - Italy.
Enrica
E
Menditto
CIRFF, Center of Pharmacoeconomics, Federico II University of Naples, Naples - Italy.
Francesca
F
Guerriero
Cardiology Department CCU, Roccadaspide Hospital, Salerno - Italy.
Raffaele
R
Rotunno
Cardiovascular risk; Inappropriate prescription; NSAIDs; Questionnaire
Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):395-405
20530789
Int J Cardiol. 2013 Sep 30;168(2):832-7
23117013
BMJ. 2006 Jun 3;332(7553):1302-8
16740558
Lancet. 2004 Dec 4-10;364(9450):2021-9
15582059
Drugs. 2003;63(6):525-34
12656651
BMJ. 2011 Jul 04;343:d3450
21727167
Aliment Pharmacol Ther. 2008 Jul;28(1):97-106
18397385
Br J Clin Pharmacol. 2008 Jun;65(6):927-34
18384446
Lancet. 2007 May 12;369(9573):1580-1
17499583
Clin Rheumatol. 2008 Sep;27(9):1191-4
18607671
Am J Cardiol. 2010 Apr 15;105(8):1102-6
20381660
J Am Med Dir Assoc. 2014 Jul;15(7):531.e11-5
24878216
Lancet. 2013 Aug 31;382(9894):769-79
23726390
Am J Cardiol. 2014 Nov 15;114(10):1523-9
25260945
BMJ. 2011 Jan 11;342:c7086
21224324
BMJ Open. 2014 Apr 08;4(4):e004059
24713211
Ann Rheum Dis. 2011 Sep;70(9):1534-41
21804100
J Gastroenterol Hepatol. 2011 Jun;26(6):1047-52
21198829
Circulation. 2007 Mar 27;115(12):1634-42
17325246
Trends Cardiovasc Med. 2015 Nov;25(8):726-35
25956433
Clin Drug Investig. 2015 Jan;35(1):1-11
25479959
Drug Saf. 2008;31(2):143-58
18217790
Am J Med. 2014 Jan;127(1):53-60.e1
24280110
Annu Rev Pharmacol Toxicol. 2009;49:265-90
18851701
Circulation. 2011 May 24;123(20):2226-35
21555710